Modulus
Facts
- HQ
- Seattle
- Sectors
- Biotech, Cell therapy
- Stage
- Seed
Recent coverage
Front-page news, podcasts and videos about Modulus
AI2 Adds Bioengineer Jenny Cronin to Incubator; Icosavax Names Bekiroglu, Russo and Two Board Members; Proprio’s CMO Browd Expands Role
AI2 hired bioengineer Jenny Cronin as a principal for its startup incubator, bringing experience from s2s Public Relations, NanoString, and a UW bioengineering Ph.D.; AI2 has incubated startups like Ozette, Modulus and MajorBoost. Seattle biotech Icosavax named Elizabeth Bekiroglu general counsel, Thomas Russo CFO, and added Heidi Kunz and Ann Veneman to its board; pediatric neurosurgeon Samuel Browd is taking partial leave from UW/Seattle Children’s to expand as CMO of surgical tech startup Proprio.
Modulus Therapeutics, spun out of the Allen Institute for AI, raises $3.5M to engineer enhanced NK cell therapies
Modulus Therapeutics, a Seattle cell-therapy startup spun out of the Allen Institute for AI, raised $3.5 million in seed funding to use lab research and machine learning to engineer enhanced natural killer (NK) cells for anti-tumor therapies. Founders Max Darnell and Bryce Daines aim to develop a discovery platform to generate NK cell product candidates for larger cellular therapy companies.
